Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Hester Biosciences Ltd.

NSE: HESTERBIO | BSE:524669

₹2655.75 142.60 (5.67%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

2507.60

Today’s High

2712.00

52W low

1292.80

52W High

2727.00

Open Price

2513.20

Prev. Close

1787.7500

Volume

38223.00

Value

101510732.25

Fundamentals

Market Cap

2259.20

Price to Earnings

119.60

Price to Book Value

7.50

Dividend Yield

0.30

PE to Growth

-4.10

Op Revenue TTM

304.55

Net Profit TTM

18.89

Cash From Operating Activity

48.13

Return on Equity %

6.47

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

5Day EMA

2538.7

10Day EMA

2460.9

12Day EMA

2427.7

20Day EMA

2305.6

26Day EMA

2230.6

50Day EMA

2029.4

100Day EMA

1837.4

200Day EMA

1734.6

5Day SMA

2516.5

10Day SMA

2514.7

20Day SMA

2262.5

30Day SMA

2099.1

50Day SMA

1944.1

100Day SMA

1702.9

150Day SMA

1633.4

200Day SMA

1635.2

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

05 Jul, 2024

44

Week

50.1

Month

36.5

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

2625.10

PIVOT

First Resistance

2742.65

Second Resistance

2829.55

Third Resistance

2947.10

First Support

2538.20

Second Support

2420.65

Third Support

2333.75

Relative Strength Index

78.28

Money Flow Index

87.92

MACD

197.08

MACD Signal

180.93

Average True Range

125.47

Average Directional Index

52.58

Rate of Change (21)

54.29

Rate of Change (125)

81.17

Commodity Channel Index

89.2

Williams %R

-8.5

BETA

1 Month

-0.2

3 Month

0.79

1 Year

0.56

3 Year

0.3

PRICE CHANGE ANALYSIS

↑ 10.64%

1 Week

Low

High

2389.6

2712

↑ 54.29%

1 Month

Low

High

1725.85

2727

↑ 64.69%

3 Months

Low

High

1549.8

2727

↑ 70.68%

6 Months

Low

High

1292.85

2727

↑ 53.47%

1 Year

Low

High

1292.85

2727

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 74.08 66.48 67.65 81.20 61.65 71.73 74.18 51.76 51.33 55.22 57.92
Operating Expenses Qtr 60.46 53.94 54.44 68.98 49.78 51.79 56.22 41.33 40.20 38.77 39.46
Operating Profit Qtr 12.41 11.57 11.99 11.37 10.92 18.99 15.78 9.20 10.05 15.23 17.14
EBIDT Qtr Cr 13.62 12.55 13.21 12.22 11.87 19.95 17.96 10.43 11.13 16.45 18.46
Depreciation Qtr 2.08 2.57 2.58 2.55 2.62 2.44 2.34 2.39 2.55 2.33 2.32
Net Profit Qtr 7.43 6.47 6.78 6.47 6.26 10.73 10.35 5.00 4.95 10.56 11.77
Basic EPS Qtr 8.74 7.61 7.97 7.61 7.36 12.61 12.16 5.88 5.82 12.41 13.84
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 289.42 259.32 224.01 210.12 172.35
Operating Expenses Annual Cr 237.81 199.11 158.78 136.48 116.70
Operating Profit Annual 47.34 54.89 60.57 71.99 52.72
Operating Profit Margin Annual % 16.36 21.17 27.04 34.26 30.59
Total Expenses Annual Cr 252.69 215.40 170.75 150.06 131.12
EBIDT Annual Cr 51.60 60.21 65.23 73.64 55.65
EBIDT Annual margin % 17.83 23.22 29.12 35.05 32.29
Depreciation 9.78 9.79 9.50 9.63 9.38
PAT Before ExtraOrdinary Items Annual Cr 27.16 32.34 39.52 39.90 31.22
Net Profit Annual 27.16 32.34 39.52 39.90 31.22
Basic EPS Annual 31.93 38.02 46.45 46.90 36.70
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 312.71 292.38 268.43 237.58 203.08
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 139.11 116.96 81.17 9.79 15.89
Total Current Liabilities Annual Cr 97.72 136.47 74.84 34.65 58.22
Total Capital Plus Liabilities Annual Cr 549.55 545.82 424.44 282.01 277.19
Fixed Assets Annual 274.86 256.82 166.22 90.23 97.64
Total Non Current Assets Annual 345.13 329.77 257.97 142.41 154.01
Total Current Assets Annual 204.41 216.05 166.47 139.61 123.18
Total Assets Annual 549.55 545.82 424.44 282.01 277.19
Contingent Liabilities plus Commitments Annual Cr - 241.23 276.50 104.93 107.06
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 42.81 33.36 15.90 40.07 25.82
Cash from Investing Activity Annual -20.63 -71.96 -110.58 -2.69 -21.33
Cash from Financing Annual Activity -24.07 41.38 94.96 -41.33 -1.39
Net Cash Flow Annual - 2.77 0.28 -3.95 3.10
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 367.59 343.69 315.54 279.28 238.72
ROE Annual % 8.68 11.06 14.72 16.79 15.37
ROCE Annual % 9.25 12.31 15.93 25.87 21.12
Total Debt to Total Equity Annual 0.43 0.56 0.45 0.02 0.19
EBDIT Annual Margin % 18.09 23.70 29.73 35.32 32.84
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 83.40 67.97 74.81 89.00 70.49 79.33 77.60 53.82 63.66 58.47 64.09
Operating Expenses Qtr 63.33 56.83 57.24 73.49 55.62 56.19 60.41 43.27 46.14 40.66 45.10
Operating Profit Qtr 15.92 10.15 13.21 14.36 11.68 18.76 12.74 7.43 10.32 15.03 17.56
EBIDT Qtr Cr 20.07 11.14 17.57 15.51 14.86 23.15 17.19 10.55 17.52 17.81 18.98
Depreciation Qtr 3.74 3.75 4.28 5.40 5.37 5.24 5.03 5.06 5.13 5.17 3.05
Net Profit Qtr 4.95 3.98 4.09 5.87 4.53 11.19 6.94 3.97 7.72 8.48 10.62
Basic EPS Qtr 7.52 4.73 4.75 7.89 6.72 14.29 7.77 4.19 10.59 9.79 13.08
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 315.18 281.24 248.75 219.02 189.63
Operating Expenses Annual Cr 250.89 215.48 175.02 145.67 127.87
Operating Profit Annual 53.66 50.61 59.98 68.66 55.40
Operating Profit Margin Annual % 17.02 17.99 24.11 31.35 29.21
Total Expenses Annual Cr 287.84 245.50 195.67 165.59 148.31
EBIDT Annual Cr 64.29 65.76 73.72 73.34 61.77
EBIDT Annual margin % 20.40 23.38 29.64 33.49 32.57
Depreciation 17.17 20.70 16.58 13.31 13.07
PAT Before ExtraOrdinary Items Annual Cr 16.56 23.63 39.06 34.70 31.00
Net Profit Annual 18.89 26.63 39.48 34.43 29.17
Basic EPS Annual 24.88 32.96 46.41 40.79 36.44
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 291.79 279.73 259.99 228.31 201.07
Minority Interest Liability Annual Cr 11.08 8.82 7.41 7.65 5.42
Total Non Current Liabilities Annual Cr 253.69 232.72 197.87 113.72 96.64
Total Current Liabilities Annual Cr 105.78 148.70 96.90 61.37 83.47
Total Capital Plus Liabilities Annual Cr 662.35 669.97 562.16 411.05 386.60
Fixed Assets Annual 411.51 407.98 319.08 241.75 216.69
Total Non Current Assets Annual 447.73 442.37 367.40 249.54 227.29
Total Current Assets Annual 214.62 227.59 194.76 161.51 159.31
Total Assets Annual 662.35 669.97 562.16 411.05 386.60
Contingent Liabilities plus Commitments Annual Cr - 126.19 170.20 2.05 1.52
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 48.13 23.60 8.81 58.05 36.77
Cash from Investing Activity Annual -22.65 -77.00 -116.59 -38.37 -74.47
Cash from Financing Annual Activity -26.05 41.76 111.61 -18.22 18.74
Net Cash Flow Annual - -11.64 3.83 1.46 -18.96
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 356.03 339.19 314.32 277.37 242.73
ROE Annual % 6.47 9.51 15.18 15.08 14.50
ROCE Annual % 8.46 8.64 12.28 17.16 16.06
Total Debt to Total Equity Annual 0.82 0.96 0.86 0.38 0.54
EBDIT Annual Margin % 21.11 24.71 31.37 34.21 33.70
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
Rajiv Dinesh Gandhi 10.47 87165027 0 0
Sanjiv Dinesh Gandhi 8.2 87165028 0 0
Nina Rajiv Gandhi 8.19 87165029 0 0
Shaila Bhupendra Gandhi 5.78 87165030 0 0
Bhupendra Vithaldas Gandhi 4.69 87165031 0 0
Anup Chandravadan Kapadia 2.68 87165032 0 0
Biolink Healthcare Limited 2.93 87165037 0 0
Hester Coatings LLP 0.75 87165038 0 0
Ravin Gandhi 4.74 87165041 0 0
Bela Gandhi 4.71 87165042 0 0
Name Holding Percent Holding Id
Name Holding Percent Holding Id
Kuntal Hasmukhlal Shah 3.07 87165056
Manish Jain 2.88 87165057
Manish Prataprai Gandhi 1.18 87165059
Jagrut Prataprai Gandhi 1.18 87165058
Sandeep Shantilal Gala 1.12 87165060
HUF 2.63 87165048
Darshna Dinesh Kapadia 1.81 87165062
Vinay Shah 1.28 87165063
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Sep 13, 2023 8 FINAL - Equity Share
Aug 11, 2022 10 FINAL - Equity Share
Aug 05, 2021 10 FINAL - Equity Share
Aug 27, 2020 6.6 FINAL - Equity Share
Jul 18, 2019 7 FINAL - Equity Share
Nov 09, 2018 2 INTERIM Nov 12, 2018 Equity Share
Aug 30, 2018 2 INTERIM Aug 31, 2018 Equity Share
Aug 02, 2018 6 FINAL - Equity Share
Nov 16, 2017 4 INTERIM Nov 17, 2017 Equity Share
Jul 20, 2017 2.3 FINAL - Equity Share
Nov 03, 2016 3 INTERIM Nov 04, 2016 Equity Share
Jul 21, 2016 1.1 FINAL - Equity Share
Mar 17, 2016 3 INTERIM Mar 18, 2016 Equity Share
Sep 10, 2015 3.1 FINAL - Equity Share
Sep 18, 2014 2 FINAL - Equity Share
Aug 07, 2013 2 FINAL - Equity Share
Aug 27, 2012 1 FINAL Aug 28, 2012 Equity Share
Aug 25, 2011 3.5 FINAL - Equity Share
Jul 22, 2010 3 FINAL - Equity Share
Aug 13, 2009 2.5 FINAL - Equity Share
Aug 21, 2008 2.5 FINAL - Equity Share
Sep 06, 2007 2 FINAL - Equity Share
Jul 07, 2006 1.5 FINAL - Equity Share
Jun 06, 2005 1.2 FINAL - Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 10, 2024 Audited Results & Dividend -
Feb 02, 2024 Quarterly Results -
Nov 07, 2023 Quarterly Results -
Aug 08, 2023 Quarterly Results -
May 17, 2023 Audited Results & Final Dividend -
Jan 31, 2023 Quarterly Results -
Nov 04, 2022 Quarterly Results -
Aug 10, 2022 Quarterly Results -
May 20, 2022 Audited Results & Dividend -
Jan 31, 2022 Quarterly Results -
Nov 13, 2021 Others -
Oct 28, 2021 Quarterly Results -
Aug 12, 2021 Quarterly Results -
Jun 08, 2021 Audited Results & Dividend -
Jan 30, 2021 Quarterly Results & Preferential Issue -
Oct 31, 2020 Quarterly Results -
Jul 30, 2020 Quarterly Results -
Jun 26, 2020 Audited Results & Dividend -
Apr 29, 2020 Others Inter alia, to consider and approve the change of Chief Financial Officer (Key Managerial Personnel) of the Company.
Mar 04, 2020 Others inter alia, consider and approve the appointment of Chief Financial Officer (CFO) and revision in list of Key Managerial Personnel (KMPs) of the Company.
Feb 07, 2020 Quarterly Results -
Dec 18, 2019 Preferential Issue of shares Inter alia, to consider and approve the proposal of raising of funds by way of issue of equity shares, and/or equity linked securities and/or securities convertible into equity shares.
Nov 06, 2019 Quarterly Results -
Jul 31, 2019 Quarterly Results -
May 07, 2019 Audited Results & Final Dividend -
Jan 29, 2019 Quarterly Results -
Oct 29, 2018 Quarterly Results & Interim Dividend -
Aug 10, 2018 Quarterly Results & Interim Dividend -
May 14, 2018 Audited Results & Final Dividend -
Jan 23, 2018 Quarterly Results -
Nov 09, 2017 Quarterly Results & Interim Dividend -
Jul 28, 2017 Quarterly Results -
May 08, 2017 Audited Results & Final Dividend -
Mar 22, 2017 Others With regard to the proposed investments in an existing partnership firm.
Jan 19, 2017 Quarterly Results -
Oct 20, 2016 Quarterly Results & Interim Dividend -
Jul 29, 2016 Quarterly Results -
Jun 29, 2016 Issue of Equity Shares -
May 07, 2016 Audited Results & Final Dividend -
Mar 10, 2016 Interim Dividend -
Feb 17, 2016 Others To allot the 65 (Sixty Five) Equity shares of the Company pursuant to Scheme of arrangement in the nature of merger & demerger and to make application to BSE and NSE for listing of further shares
Jan 25, 2016 Quarterly Results -
Oct 26, 2015 Quarterly Results -
Aug 11, 2015 Appointment & Resignation of Director -
Jul 22, 2015 Quarterly Results -
May 28, 2015 Audited Results & Dividend -
Mar 28, 2015 Re-appointment Independent Directors to discuss and finalise re-appointment terms of Independent Directors of the Company.
Jan 21, 2015 Quarterly Results -
Dec 24, 2014 Merger / Demerger The Company has proposed for the merger / demerger of some of its group Companies.
Oct 18, 2014 Quarterly Results -
Jul 24, 2014 Quarterly Results -
May 30, 2014 Audited Results & Dividend -
Jan 28, 2014 Quarterly Results -
Oct 28, 2013 Quarterly Results -
Aug 14, 2013 Quarterly Results -
May 30, 2013 Audited Results & Dividend -
Jan 29, 2013 Quarterly Results -
Nov 09, 2012 Quarterly Results -
Oct 01, 2012 Allotment of Bonus Shares To consider and make allotment of Bonus Shares in the proportion of 1 (One) new equity share of Rs. 10/- each for every 2 (Two) existing fully paid up equity shares of Rs. 10/- each.
Aug 14, 2012 Audited Results & Bonus issue The Board has approved to issue of Bonus Equity Shares in the ratio of 1:2 i.e. 1 (One) new share for every existing 2 (Two) Shares held by the members.
May 15, 2012 Quarterly Results -
Feb 11, 2012 Allotment of Equity Shares For allotment of 480,000 Equity Shares of Rs. 10.00 each at, a price of Rs. 137.00 per Share (which includes a share premium of Rs. 127.00 per Share) to Promoters/Promoter Groups & Non Promoters.
Feb 04, 2012 Quarterly Results -
Oct 20, 2011 Quarterly Results -
Jul 19, 2011 Quarterly Results -
May 24, 2011 Audited Results & Dividend -
Feb 03, 2011 Quarterly Results -
Oct 25, 2010 Quarterly Results -
Jul 28, 2010 Quarterly Results -
Jul 02, 2010 To consider raising of funds To raise Rs. 65.76 million through the issue of 480,000 Equity Warrants on preferential basis to the Promoters/Non Promoters of the Company, with each Warrant Conv. into 1 Equity Share of the Company.
May 23, 2010 Audited Results & Dividend -
Jan 27, 2010 Quarterly Results -
Oct 14, 2009 Quarterly Results -
Jul 10, 2009 Quarterly Results -
Jun 30, 2009 Audited Results & Dividend -
May 02, 2009 Others To appoint Mr. Praful R Amin as a Non Executive Independent Director w.e.f. May 02, 2009 & to reconstitute the Audit Committee, Remuneration Committee & Shareholders Grievance Committee.
Jan 20, 2009 Quarterly Results -
Oct 24, 2008 Quarterly Results -
Jul 22, 2008 Quarterly Results -
Jun 24, 2008 Audited Results & Dividend -
Jan 21, 2008 Quarterly Results -
Oct 18, 2007 Quarterly Results -
Jul 26, 2007 Quarterly Results -
Jun 27, 2007 Audited Results & Dividend -
Mar 23, 2007 Commencement of production To discuss the issues related to the commencement of production in the new manufacturing facility.
Jan 30, 2007 Quarterly Results -
Oct 31, 2006 Quarterly Results -
Jul 31, 2006 Quarterly Results -
Apr 28, 2006 Accounts & Dividend -
Mar 10, 2006 Draft Letter of Offer To approve the Draft Letter of Offer (LOF) for the proposed right issue of the Company.
Jan 10, 2006 Quarterly Results -
Dec 29, 2005 Preferential Issue of shares To approve allotment of 1,80,800 equity shares of Rs.10/- each at a premium of Rs.140/- each.
Dec 15, 2005 Appointment of lead managers To consider the appointment of lead managers and various other agencies for the preferential alotment and for the right issue of equity shares.
Nov 15, 2005 Right Issue of Equity Shares -
Oct 25, 2005 Quarterly Results -
Aug 16, 2005 Expansion Plan & Raising of funds To consider and discuss the outcome of the committee meeting for raising the finance for expansion project.
Jul 28, 2005 Rights Issue -
Apr 21, 2005 Accounts & Dividend Also to consider demise of the Company's Chairman Dr V A Padval and to appoint a new Chairman for the Company & To declare and pay 8% dividend on Preference Shares.
Mar 02, 2005 Others To take decision for the redemption of redeemable preference shares and payment of dividend on the same.
Jan 20, 2005 Quarterly Results -
Oct 27, 2004 Quarterly Results -
Jul 30, 2004 Quarterly Results -
Jun 28, 2004 Accounts -
Jan 29, 2004 Quarterly Results -
Oct 10, 2003 Quarterly Results -
Jul 29, 2003 Quarterly Results -
Jun 27, 2003 Accounts -
Jan 31, 2003 Quarterly Results -
Oct 29, 2002 Quarterly Results -
Jul 30, 2002 Quarterly Results -
Jun 29, 2002 Accounts -
Jan 31, 2002 Quarterly Results -
Oct 25, 2001 Half Yearly Results -
Jul 21, 2001 Quarterly Results -
May 25, 2001 Accounts -
Apr 06, 2001 Others To shift the Registered office of the Company at Factory
Feb 05, 2001 Quarterly Results Revised.
Jan 29, 2001 Quarterly Results -
Oct 20, 2000 Half Yearly Results -
Jul 27, 2000 Quarterly Results -
Jun 30, 2000 Accounts -
Jan 28, 2000 Quarterly Results -
Oct 28, 1999 Quarterly Results -
Jul 31, 1999 Quarterly Results -
May 31, 1999 Accounts -
Jan 29, 1999 Quarterly Results and Cum Red Pre Share -
Jan 18, 1999 Quarterly Results -
Jul 27, 1998 Quarterly Results -
Jun 27, 1998 Accounts -
Ex-Date Bonus Ratio Record Date
Sep 27, 2012 1:2 -
Bigul
05 Jul 2024

HESTER BIOSCIENCES LTD. - 524669 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Confirmation certificate for the Quarter ended 30 June 2024
Bigul
03 Jul 2024

HESTER BIOSCIENCES LTD. - 524669 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Details of Loss of Certificate request received from the Shareholder.
Bigul
27 Jun 2024

HESTER BIOSCIENCES LTD. - 524669 - Closure of Trading Window

 Closure of Trading Window
Bigul
25 Jun 2024

HESTER BIOSCIENCES LTD. - 524669 - Reply To Clarification Sought On Price Movement

 Company response to clarification sought on price and volume movement.
Bigul
24 Jun 2024

HESTER BIOSCIENCES LTD. - 524669 - Clarification sought from Hester Biosciences Ltd

 The Exchange has sought clarification from Hester Biosciences Ltd on June 24, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
Bigul
16 May 2024

HESTER BIOSCIENCES LTD. - 524669 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 In compliance with the Regulation 24A of Listing Regulations, Annual Secretarial Compliance Report of the Company for the year ended 31 March 2024
Bigul
14 May 2024

HESTER BIOSCIENCES LTD. - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Transcripts of earnings conference call held on 10 May 2024
Bigul
11 May 2024

HESTER BIOSCIENCES LTD. - 524669 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Clippings dated 11 May 2024 - Extract of Financial Results
10 May 2024

Hester Biosciences Results Earnings Call for Q4FY24

 Conference Call with Hester Biosciences Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.
Bigul
10 May 2024

HESTER BIOSCIENCES LTD. - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Audio recording of the Earnings Conference Call held on 10 May 2024
See all News

FAQs

The latest market price of Hester Biosciences Ltd. on NSE was Rs. 2655.75 as of today.

The opening share price of Hester Biosciences Ltd. was Rs. 2513.20 as of today.

The 52-week high share price of Hester Biosciences Ltd. was Rs. 2727.00.

The 52 week low share price of Hester Biosciences Ltd. was Rs. 1292.80.

Please find Corporate actions section for more details.

The PE ratio of Hester Biosciences Ltd. is -4.10. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Hester Biosciences Ltd. was on 2023-09-13 for Rs. 8 per share. According to today’s share price, the dividend yield of Hester Biosciences Ltd. stands at 0.30. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Hester Biosciences Ltd. was as of 2012-09-27. The bonus ratio declared in this issue was 1:2. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Hester Biosciences Ltd..

Close

Let's Open Free Demat Account